|
[1]WIESE S, HOVE JD, BENDTSEN F, et al.Cirrhotic cardiomyopathy:pathogenesis and clinical relevance[J].Nat Rev Gastroenterol Hepatol, 2014, 11 (3) :177-186.
|
|
[2]MOLLER S, BENDTSEN F.Cirrhotic multiorgan syndrome[J].Dig Dis Sci, 2015, 60 (11) :3209-3225.
|
|
[3]GENOT N, MEWTON N, BRESSON D, et al.Bioelectrical impedance analysis for heart failure diagnosis in the ED[J].Am J Emerg Med, 2015, 33 (8) :1025-1029.
|
|
[4]GOPAL DJ, IQBAL MN, MAISEL A.Updating the role of natriuretic peptide levels in cardiovascular disease[J].Postgrad Med, 2011, 123 (6) :102-113.
|
|
[5]LJUBICˇIC'N, GOMERCIC M, ZEKANOVIC D, et al.New insight into the role of NT-pro BNP in alcoholic liver cirrhosis as a noninvasive marker of esophageal varices[J].Croat Med J, 2012, 53 (4) :374-378.
|
|
[6]TUXUNGULI T, AIERKEN A, XIE X, et al.Association study of plasma NT-pro BNP levels and severity of acute coronary syndrome[J].Genet Mol Res, 2014, 13 (3) :5754-5757.
|
|
[7]NIU JM, MA ZL, XIE C, et al.Association of plasma B-type natriuretic peptide concentration with myocardial infarct size in patients with acute myocardial infarction[J].Genet Mol Res, 2014, 13 (3) :6177-6183.
|
|
[8]GARIANI K, DELABAYS A, PERNEGER TV, et al.Use of brain natriuretic peptide to detect previously unknown left ventricular dysfunction in patients with acute exacerbation of chronic obstructive pulmonary disease[J].Swiss Med Wkly, 2011, 141:w13298.
|
|
[9]GALE CP, WHITE JE, HUNTER A, et al.Predicting mortality and hospital admission in patients with COPD:significance of NT pro-BNP, clinical and echocardiographic assessment[J].J Cardiovasc Med (Hagerstown) , 2011, 12 (9) :613-618.
|
|
[10]CHOU YH, CHEN YF, PAN SY, et al.The role of brain natriuretic peptide in predicting renal outcome and fluid management in critically ill patients[J].J Formos Med Assoc, 2015, 114 (12) :1187-1196.
|
|
[11]de CAL M, HAAPIO M, CRUZ DN, et al.B-type natriuretic Peptide in the critically ill with acute kidney injury[J].Int J Nephrol, 2011, 2011:951629.
|
|
[12]YOSHITOMI R, NAKAYAMA M, SAKOH T, et al.Plasma Btype natriuretic peptide concentration is independently associated with kidney function decline in Japanese patients with chronic kidney disease[J].J Hypertens, 2016, 34 (4) :753-761.
|
|
[13]FATTOUH AM, EL-SHABRAWI MH, MAHMOUD EH, et al.Evaluation of cardiac functions of cirrhotic children using serum brain natriuretic peptide and tissue Doppler imaging[J].Ann Pediatr Cardiol, 2016, 9 (1) :22-28.
|
|
[14]SHI LY, JIN R, LIN CJ, et al.B-type natriuretic peptide and cirrhosis progression[J].Genet Mol Res, 2015, 14 (2) :5188-5196.
|
|
[15]RADVAN M, SVOBODA P, RADVANOVA J, et al.Brain natriuretic peptide in decompensation of liver cirrhosis in non-cardiac patients[J].Hepatogastroenterology, 2009, 56 (89) :181-185.
|
|
[16]METWALY A, KHALIK AA, NASR FM, et al.Brain natriuretic peptide in liver cirrhosis and fatty liver:correlation with cardiac performance[J].Electron Physician, 2016, 8 (2) :1984-1993.
|
|
[17]RUNYON BA, COMMITTEE APG.Management of adult patients with ascites due to cirrhosis:an update[J].Hepatology, 2009, 49 (6) :2087-2107.
|
|
[18]LICATA A, CORRAO S, PETTA S, et al.NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis[J].PLo S One, 2013, 8 (8) :e68364.
|
|
[19]RUNYON BA.Cardiac ascites:a characterization[J].J Clin Gastroenterol, 1988, 10 (4) :410-412.
|
|
[20]UDDIN MS, HOQUE MI, ISLAM MB, et al.Serum-ascites albumin gradient in differential diagnosis of ascites[J].Mymensingh Med J, 2013, 22 (4) :748-754.
|
|
[21]BEGUM N, AFROZA A, KARIM BM.Evaluation of correlation between high serum-ascites albumin gradient and the upper gastrointestinal endoscopic parameters in children presenting with portal hypertension with ascites[J].Mymensingh Med J, 2014, 23 (4) :703-708.
|
|
[22]FARIAS AQ, SILVESTRE OM, GARCIA-TSAO G, et al.Serum B-type natriuretic peptide in the initial workup of patients with new onset ascites:a diagnostic accuracy study[J].Hepatology, 2014, 59 (3) :1043-1051.
|
|
[23]ESPINOSA MD, OLMEDO C, MUFFAK-GRANERO K, et al.Preoperative natriuretic peptide-B values and ascites in male liver transplant recipients[J].Transplant Proc, 2011, 43 (3) :705-707.
|
|
[24]KRISHNAN A, SRINIVASAN V, VENKATARAMAN J.Variceal recurrence, rebleeding rates and alterations in clinical and laboratory parameters following post-variceal obliteration using endoscopic sclerotherapy[J].J Dig Dis, 2012, 13 (11) :596-600.
|
|
[25]BORTOLUZZI A, CEOLOTTO G, GOLA E, et al.Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites:molecular mechanisms[J].Hepatology, 2013, 57 (1) :266-276.
|
|
[26]MANI AR, IPPOLITO S, CENTELLES MN, et al.Nitric oxidedependent bradycardia in mutant analbuminemic rats[J].Biochem Pharmacol, 2012, 84 (8) :1062-1069.
|
|
[27]MERCANTINI P, di SOMMA S, MAGRINI L, et al.Preoperative brain natriuretic peptide (BNP) is a better predictor of adverse cardiac events compared to preoperative scoring system in patients who underwent abdominal surgery[J].World J Surg, 2012, 36 (1) :24-30.
|
|
[28]MATUCHANSKY C.Bacterial translocation in liver cirrhosis:site and role in fibrogenesis[J].J Hepatol, 2014, 61 (3) :709-710.
|
|
[29]PADILLO J, RIOJA P, MUNOZ-VILLANUEVA MC, et al.BNP as marker of heart dysfunction in patients with liver cirrhosis[J].Eur J Gastroenterol Hepatol, 2010, 22 (11) :1331-1336.
|
|
[30]VOIOSU A, WIESE S, VOIOSU T, et al.Bile acids and cardiovascular function in cirrhosis[J].Liver Int, 2017, 37 (10) :1420-1430.
|
|
[31]HAMMAMI R, BOUDABBOUS M, JDIDI J, et al.Cirrhotic cardiomyopathy:is there any correlation between the stage of cardiac impairment and the severity of liver disease?[J].Libyan J Med, 2017, 12 (1) :1283162.
|
|
[32]MERLI M, CALICCHIA A, RUFFA A, et al.Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease[J].Eur J Intern Med, 2013, 24 (2) :172-176.
|
|
[33]FERNANDEZ JJO, MOYA AF, RODRIGUEZ AL, et al.Study of arterial blood gases in liver cirrhosis with and without ascites[J].Rev Esp Enferm Dig, 1996, 88 (3) :197-201.
|
|
[34]NAQVI IH, MAHMOOD K, NAEEM M, et al.The heart matters when the liver shatters!Cirrhotic cardiomyopathy:frequency, comparison, and correlation with severity of disease[J].Prz Gastroenterol, 2016, 11 (4) :247-256.
|
|
[35]MERLI M, TORROMEO C, GIUSTO M, et al.Survival at 2 years among liver cirrhotic patients is influenced by left atrial volume and left ventricular mass[J].Liver Int, 2017, 37 (5) :700-706.
|
|
[36]MOCARZEL LO, BICCA J, JARSKE L, et al.Cirrhotic cardiomyopathy:another case of a successful approach to treatment of hepatorenal syndrome[J].Case Rep Gastroenterol, 2016, 10 (3) :531-537.
|
|
[37]MOCARZEL L, LANZIERI P, NASCIMENTO J, et al.Hepatorenal syndrome with cirrhotic cardiomyopathy:case report and literature review[J].Case Rep Hepatol, 2015, 2015:573513.
|
|
[38]KRAG A, BENDTSEN F, BURROUGHS AK, et al.The cardiorenal link in advanced cirrhosis[J].Med Hypotheses, 2012, 79 (1) :53-55.
|
|
[39]KOMEICHI H, MOREAU R, CAILMAIL S, et al.Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis[J].J Hepatol, 1995, 22 (3) :319-325.
|
DownLoad: